Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
CollaboratorsChizzolini, Carlo; Allali, Danièle
Published inAnnals of the Rheumatic Diseases, vol. 78, no. 5, p. 648-656
Publication date2019
Abstract
Keywords
- Adult
- Cohort Studies
- Databases
- Factual
- Disease Progression
- Europe
- Female
- Fibrosis
- Humans
- Kaplan-Meier Estimate
- Lung/physiopathology
- Male
- Middle Aged
- Scleroderma
- Diffuse/complications/mortality/pathology
- Severity of Illness Index
- Skin/pathology
- Skin Diseases/etiology/mortality/physiopathology
- Survival Analysis
- Time Factors
Affiliation entities
Citation (ISO format)
WU, Wanlong et al. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. In: Annals of the Rheumatic Diseases, 2019, vol. 78, n° 5, p. 648–656. doi: 10.1136/annrheumdis-2018-213455
Main files (1)
Article (Published version)
Identifiers
- PID : unige:139862
- DOI : 10.1136/annrheumdis-2018-213455
- PMID : 30852552
Journal ISSN0003-4967
